Price (delayed)
$8.02
Market cap
$101.86M
P/E Ratio
28.64
Dividend/share
$0.15
EPS
$0.28
Enterprise value
$98.01M
LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.